Background illustration for clinical trials search

Paid Clinical Trials Houston

Discover 3,116 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma

for
Ovarian Cancer, Cholangiocarcinoma Recurrent,
Location: Houston TX, Tampa FL, Madison WI, Philadelphia PA
Sponsor: Verismo Therapeutics

Sex: All

Age: 18+

Code: NCT05568680

Phase 1, Recruiting

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

for
Urothelial Carcinoma
Location: Houston TX, Oklahoma City OK, Tallahassee FL,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer

Sex: All

Age: 18+

Code: NCT04879329

Phase 2, Recruiting

Study of eFT226 in Subjects With Selected Advanced Solid Tumor Malignancies

for
Solid Tumor, Adult
Location: Houston TX, Grand Rapids MI, Fairfax VA, Los Angeles CA,
Sponsor: Effector Therapeutics

Sex: All

Age: 18+

Code: NCT04092673

Phase 1, Phase 2, Recruiting

A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo

for
NonSegmental Vitiligo
Location: Bellaire TX, Austin TX, San Antonio TX, Frisco TX,
Sponsor: Incyte Corporation

Sex: All

Age: 2 - 11

Code: NCT06548360

Phase 3, Recruiting

A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus

for
SLE, SLE (Systemic Lupus)
Location: Webster TX, Plano TX, Memphis TN, Orlando FL,
Sponsor: Cullinan Therapeutics Inc.

Sex: All

Age: 18 - 70

Code: NCT06613360

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

CER-1236 in Patients With Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), and Myelofibrosis (MF)

for
AML, Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia
Location: Houston TX, Nashville TN, Denver CO, Sacramento CA,
Sponsor: CERo Therapeutics Holdings, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06834282

Phase 1, Recruiting

The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease

for
Sickle Cell Disease
Location: Houston TX, Shreveport LA, Flowood MS, Memphis TN,
Sponsor: Sanofi

Sex: All

Age: 10 - 65

Code: NCT06975865

Phase 3, Recruiting

MAGIC Ruxolitinib for aGVHD

for
Acute Graft-versus-host Disease,
Location: Houston TX, Fairway KS, Nashville TN, Atlanta GA,
Sponsor: John Levine

Sex: All

Age: 18+

Code: NCT06936566

Phase 2, Recruiting

Preterm Functional Early Enteral Development (FEED) Trial on Respiratory Support

for
Premature Birth
Location: Houston TX
Sponsor: The University of Texas Health Science Center, Houston

Sex: All

Age: 0+

Code: NCT04531566

Recruiting

BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia

for
Advanced Solid Tumor, TNBC - Triple-Negative Breast Cancer,
Location: Houston TX, Dallas TX, Atlanta GA, Coral Gables FL,
Sponsor: SillaJen, Inc.

Sex: All

Age: 18+

Code: NCT05768932

Phase 1, Recruiting

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

for
Chronic Lymphocytic Leukemia (CLL),
Location: Houston TX, Nashville TN, Denver CO, Chicago IL,
Sponsor: Nurix Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT04830137

Phase 1, Recruiting

Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

for
Refractory Ewing Sarcoma, Relapsed Ewing Sarcoma, Ewing Sarcoma
Location: Houston TX, Dallas TX, Memphis TN, Atlanta GA,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 2 - 30

Code: NCT05734066

Phase 1, Phase 2, Recruiting

Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome

for
Acute Myeloid Leukemia,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 12+

Code: NCT03383575

Phase 2, Recruiting

Phase 1 Dose Escalation and Dose Expansion Trial of NP-101 in Patients With Solid Tumors

for
Solid Tumor
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06563375

Phase 1, Recruiting

A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma

for
Glioblastoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06672575

Phase 1, Phase 2, Recruiting

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

for
Metastatic Castration-resistant Prostate Cancer (mCRPC),
Location: Houston TX, Austin TX, Dallas TX, Germantown TN,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136650

Phase 3, Recruiting